Ranch Capital Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Ranch Capital Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-50	Closed	-$9K	–	585
2021 Q3	$9K	Sell	50 -13	-21%	-$2.54K	0.01%	493
2021 Q2	$12K	Sell	63 -15	-19%	-$3.14K	0.01%	615
2021 Q1	$16K	Sell	78 -393	-83%	-$86.3K	0.01%	517
2020 Q4	$111K	Sell	471 -449	-49%	-$103K	0.08%	191
2020 Q3	$256K	Buy	920 +55	+6%	+$15.2K	0.21%	116
2020 Q2	$232K	Buy	+865	New	+$235K	0.18%	128

Other funds holding VRTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Ranch Capital Advisors's VRTX Position: Q4 2021 in Review

Ranch Capital Advisors sold out of Vertex Pharmaceuticals (VRTX) in Q4 2021, closing a stake of 50 shares — an estimated $9K sold.

Ranch Capital Advisors first reported a position in VRTX in Q2 2020 and held it in 6 quarters. The position peaked at $256K in Q3 2020. 1,033 funds tracked by Wall St. Rank hold VRTX as of Q4 2021.

Ranch Capital Advisors reported no remaining Vertex Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
Ranch Capital Advisors sold 50 Vertex Pharmaceuticals shares in Q4 2021, an estimated $9K.
Ranch Capital Advisors first reported a position in Vertex Pharmaceuticals in Q2 2020 and held it in 6 quarters.
Ranch Capital Advisors's Vertex Pharmaceuticals position peaked at $256K in Q3 2020.
1,033 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2021.

Based on Ranch Capital Advisors's 13F filing for Q4 2021, filed 8 Feb 2022.